The journal impact factors for 2013 have recently been announced by Thomson Reuters.
The journal impact factor is a measure of how frequently papers from that particular journal are quoted. It is a pleasure to announce that the journal impact factor for the Journal of Cystic Fibrosis has increased this year to 3.82. This is the highest our impact factor has been since the journal started and reflects the high quality of papers published now in JCF. The Board of ECFS extends its congratulations to the Senior Editor Prof. Scott Bell, Dr Harry Heijerman who has been acting Editor-in-Chief during the second half of 2013 and is our founding Editor, Prof. Dominik Hartl who is the Deputy Editor and the Editorial Board for their sterling work over the past years to achieve this. The increase in the impact factor is also a testimony to the skill and commitment which Gerd Döring brought to the Journal before his untimely death. He would have been very pleased with the increase in the impact factor and the calculation is primarily related to his time as Editor-in-Chief.
JCF now ranks tenth in the Respiratory category, which further emphasises the excellent progress and achievements of the Journal. On behalf of the ECFS Board I would like to thank you also for continuing to support the journal and encourage you to send your best work to us for review.